In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 3, 2003, Pages 497-499

  Miyashita, Naoyuki ^a   Fukano, Hiroshi ^a   Yoshida, Koichiro ^a   Niki, Yoshihito ^a   Matsushima, Toshiharu ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Community acquired pneumonia; Macrolides; Telithromycin

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; CETHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; KETOLIDE; TELITHROMYCIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CHLAMYDOPHILA PNEUMONIAE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RESPIRATORY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; ERYTHROMYCIN; HUMANS; JAPAN; KETOLIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS;

EID: 0141629289     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg371     Document Type: Article

References (13)

1. Andrews, J. M., Weller, T. M. A., Ashby, J. P. et al. (2000). The in vitro activity of ABT 773, a new ketolide antimicrobial agent. Journal of Antimicrobial Chemotherapy 46, 1017-22.
2. Nilius, A. M., Bui, M. H., Almer, L. et al. (2001). Comparative in vitro activity of ABT-773, a novel antibacterial ketolide. Antimicrobial Agents and Chemotherapy 45, 2163-8.
3. Kuo, C. C., Jackson, L. A., Campbell, L. A. et al. (1995). Chlamydia pneumoniae (TWAR). Clinical Microbiology Reviews 8, 451-61.
4. Strigl, S., Roblin, P. M., Reznik, T. et al. (2000). In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae. Antimicrobial Agents and Chemotherapy 44, 1112-3.
5. Roblin, P. M. & Hammerschlag, M. R. (1998). In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae. Antimicrobial Agents and Chemotherapy 42, 1515-6.
6. Niki, Y., Kimura, M., Miyashita, N. et al. (1994). In vitro and in vivo activities of azithromycin, a new azalide antibiotic, against Chlamydia. Antimicrobial Agents and Chemotherapy 38, 2296-9.
7. Miyashita, N., Niki, Y., Kishimoto, T. et al. (1997). In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp. Antimicrobial Agents and Chemotherapy 41, 1331-4.
8. Miyashita, N., Fukano, H., Niki, Y. et al. (2001). In vitro activity of telithromycin, a new ketolide, against Chlamydia pneumoniae. Journal of Antimicrobial Chemotherapy 48, 403-5.
9. Hammerschlag, M. R., Reznik, T., Roblin, P. M. et al. (2003). Microbiological efficacy of ABT-773 (cethromycin) for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae. Journal of Antimicrobial Chemotherapy 51, 1025-8.
10. Tellier, G., Hassman, J., Leroy, B. et al. (2000). Oral telithromycin (HMR 3647 800 mg od) is well tolerated and as effective as oral clarithromycin (500 mg bid) in community-acquired pneumonia (CAP) in adults. In Program and Abstracts of the Fortieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 2000. Abstract 2227, p. 471. American Society for Microbiology, Washington, DC, USA.
11. Pullman, J., Champlin, J., Leroy, B. et al. (2000). Oral telithromycin (HMR 3647; 800 mg OD) for 7-10 days is well tolerated and as effective as oral trovafloxacin (200 mg OD) for 7-10 days in community-acquired pneumonia (CAP) in adults. In Program and Abstracts of the Fortieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 2000. Abstract 2230, p. 472. American Society for Microbiology, Washington, DC, USA.
12. Block, S., Hedrick, J., Hammerschlag, M. R. et al. (1995). Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatric Infectious Disease Journal 14, 471-7.
13. Roblin, P. M. & Hammerschlag, M. R. (1998). Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia. Antimicrobial Agents and Chemotherapy 42, 194-6.